Valuation Update With 7 Day Price Move • Jul 01
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €26.82, the stock trades at a forward P/E ratio of 40x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 981% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €26.71 per share. Duyuru • May 09
5N Plus Announces Election of Board Members 5N Plus Inc. at its Annual General Meeting of Shareholders held on May 7, 2026, the directors appointed Mr. Gervais Jacques as Executive Chairman of the Board of Directors of the Company. Michael Hanley and Richard Perron appointed as directors. Duyuru • Apr 29
5N Plus Inc. to Report Q1, 2026 Results on May 06, 2026 5N Plus Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026 Duyuru • Apr 14
5N Plus Inc. Announces Chief Financial Officer Changes 5N Plus Inc. announced the appointment of Mr. Alban Fournier as Chief Financial Officer, effective April 27, 2026. Mr. Fournier joins 5N+ with nearly 30 years of experience across three continents in corporate and operational roles, with deep expertise in finance, internal audit, corporate strategy and technology. He most recently served as Chief Financial and Technology Officer at the Montreal Port Authority, where he also oversaw procurement. Previously, he was CFO at Chantier Davie Canada Inc. Prior to that, he spent more than two decades with Rio Tinto, where he held several senior leadership roles, including group head of internal audit and CFO of Rio Tinto Bauxite & Alumina. A graduate of Sciences Po Paris (Paris Institute of Political Studies), he holds a master's degree in finance and economics. This appointment follows the Company's previously announced leadership succession plan under which Richard Perron, current CFO, will become President and Chief Executive Officer (CEO) and Gervais Jacques, current CEO, will become Executive Chair of the Board effective May 31, 2026. Duyuru • Mar 18
5N Plus Inc. Announces Jean-Marie Bourassa, Member of the Board Will Not Be Standing for Re-Election 5N Plus Inc. announced that Mr. Jean-Marie Bourassa, member of the Board since 2007, will not be standing for re-election. Duyuru • Mar 03
5N Plus Inc., Annual General Meeting, May 07, 2026 5N Plus Inc., Annual General Meeting, May 07, 2026. Duyuru • Feb 17
5N Plus Inc. to Report Q4, 2025 Results on Feb 24, 2026 5N Plus Inc. announced that they will report Q4, 2025 results on Feb 24, 2026 Duyuru • Oct 27
5N Plus Inc. to Report Q3, 2025 Results on Nov 03, 2025 5N Plus Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2025 Duyuru • Jul 28
5N Plus Inc. to Report Q2, 2025 Results on Aug 04, 2025 5N Plus Inc. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025 Duyuru • Apr 29
5N Plus Inc. to Report Q1, 2025 Results on May 07, 2025 5N Plus Inc. announced that they will report Q1, 2025 results After-Market on May 07, 2025 Duyuru • Mar 04
5N Plus Inc., Annual General Meeting, May 08, 2025 5N Plus Inc., Annual General Meeting, May 08, 2025. Duyuru • Feb 18
5N Plus Inc. to Report Q4, 2024 Results on Feb 25, 2025 5N Plus Inc. announced that they will report Q4, 2024 results After-Market on Feb 25, 2025 Reported Earnings • Nov 06
Third quarter 2024 earnings released: EPS: US$0.07 (vs US$0.017 in 3Q 2023) Third quarter 2024 results: EPS: US$0.07 (up from US$0.017 in 3Q 2023). Revenue: US$78.8m (up 25% from 3Q 2023). Net income: US$6.37m (up 320% from 3Q 2023). Profit margin: 8.1% (up from 2.4% in 3Q 2023). Revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Duyuru • Oct 28
5N Plus Inc. to Report Q3, 2024 Results on Nov 04, 2024 5N Plus Inc. announced that they will report Q3, 2024 results After-Market on Nov 04, 2024 Recent Insider Transactions • Sep 19
Chief Financial Officer recently sold €581k worth of stock On the 11th of September, Richard Perron sold around 125k shares on-market at roughly €4.64 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Richard has been a net seller over the last 12 months, reducing personal holdings by €377k. Reported Earnings • Aug 06
Second quarter 2024 earnings released: EPS: US$0.05 (vs US$0.12 in 2Q 2023) Second quarter 2024 results: EPS: US$0.05 (down from US$0.12 in 2Q 2023). Revenue: US$74.6m (up 26% from 2Q 2023). Net income: US$4.79m (down 53% from 2Q 2023). Profit margin: 6.4% (down from 17% in 2Q 2023). Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Germany. Duyuru • Jul 29
5N Plus Inc. to Report Q2, 2024 Results on Aug 05, 2024 5N Plus Inc. announced that they will report Q2, 2024 results After-Market on Aug 05, 2024 Recent Insider Transactions • Jun 14
Chief Financial Officer recently sold €144k worth of stock On the 11th of June, Richard Perron sold around 35k shares on-market at roughly €4.10 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months. New Risk • Jun 14
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €0 This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Large one-off items impacting financial results. Significant insider selling over the past 3 months (€0 sold). Recent Insider Transactions • May 19
Independent Director recently bought €70k worth of stock On the 15th of May, Jean-Marie Bourassa bought around 20k shares on-market at roughly €3.52 per share. This transaction amounted to 1.2% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €185k. Insiders have collectively bought €549k more in shares than they have sold in the last 12 months. Duyuru • May 11
5N Plus Inc. Appoints Andrée-Lise Méthot as Director 5N Plus Inc. announced that at its Annual General Meeting of Shareholders held on May 9, 2024, Approved the appointment of Andrée-Lise Méthot as director. Reported Earnings • May 08
First quarter 2024 earnings released: EPS: US$0.03 (vs US$0.016 in 1Q 2023) First quarter 2024 results: EPS: US$0.03 (up from US$0.016 in 1Q 2023). Revenue: US$65.0m (up 18% from 1Q 2023). Net income: US$2.51m (up 72% from 1Q 2023). Profit margin: 3.9% (up from 2.6% in 1Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Duyuru • May 01
5N Plus Inc. to Report Q1, 2024 Results on May 06, 2024 5N Plus Inc. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on May 06, 2024 Duyuru • Mar 24
5N Plus Inc. Launches the Commercialization Rights for Its Portfolio of Gallium Nitride on Silicon (Gan-On-Si) Patents 5N Plus Inc. announced that it is officially launching the commercialization rights for its portfolio of gallium nitride on silicon (GaN-on-Si) patents that will take semiconductors and power switching technology to the next level. These key patents can enable the rapid prototype development and first-to-market commercialization of novel vertical GaN-on-Si power devices by companies operating in the High-Power Electronics (HPE), Electric Vehicles (EV) and Artificial Intelligence (AI) server sectors. A mechanically stable, wide-bandgap semiconductor material with high heat capacity and thermal conductivity, GaN has outstanding properties. Today, lateral GaN is primarily used in low voltage (<400V) applications, such as chargers, but novel vertical GaN- on-Si has the potential to replace silicon carbide (SiC), which is the current preferred material for medium and high voltage applications (i.e. EV inverters operating 650V). SiC is expensive and not easily available, whereas GaN-on-Si is more efficient and cost-effective. Recent academic demonstrations utilizing key 5N+ patents have shown that vertical GaN-on- Si, as opposed to lateral GaN transistors showing destructive breakdown, offers soft breakdown with avalanche capability for safe, compact and more efficient devices. Also included in this patent is the ability to remove the substrate to form the backside contacts once the GaN growth is complete. In addition, the Company holds lateral GaN-on-Si patents for radiofrequency (RF) applications that will enable next generation 5G and 6G wireless communication components. 5N+ holds these patents through its wholly owned subsidiary AZUR SPACE Solar Power GmbH, a leader in multi-junction solar cell technology. About 5N+ is a leading global producer of specialty semiconductors and performance materials. The Company's ultra-pure materials often form the core element of its customers' products. These customers rely on 5N+'s products to enable performance and sustainability in their own products. 5N+ deploys a range of proprietary and proven technologies to develop and manufacture its products. The Company's products enable various applications in several key industries, including renewable energy, security, space, pharmaceutical, medical imaging and industrial. Headquartered in Montreal, Quebec, 5N+ operates R&D, manufacturing and commercial centers in strategically located facilities around the world including Europe, North America and Asia. Recent Insider Transactions • Mar 15
Independent Chairman recently bought €98k worth of stock On the 13th of March, Luc Bertrand bought around 32k shares on-market at roughly €3.07 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €185k. Luc has been a buyer over the last 12 months, purchasing a net total of €234k worth in shares. Recent Insider Transactions • Mar 06
Independent Director recently bought €185k worth of stock On the 1st of March, Jean-Marie Bourassa bought around 60k shares on-market at roughly €3.08 per share. This transaction amounted to 3.8% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €118k more in shares than they have sold in the last 12 months. New Risk • Mar 04
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 56% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.3x net interest cover). Minor Risk Large one-off items impacting financial results. Duyuru • Mar 02
5N Plus Inc., Annual General Meeting, May 09, 2024 5N Plus Inc., Annual General Meeting, May 09, 2024. Duyuru • Mar 01
5N Plus Inc. Reports Impairment Results for the Fourth Quarter of 2023 5N Plus Inc. reported impairment results for the fourth quarter of 2023. for the quarter, the company reported impairment of $64,000. Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: US$0.17 (vs US$0.26 loss in FY 2022) Full year 2023 results: EPS: US$0.17 (up from US$0.26 loss in FY 2022). Revenue: US$242.4m (down 8.3% from FY 2022). Net income: US$15.4m (up US$38.4m from FY 2022). Profit margin: 6.4% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Duyuru • Feb 21
5N Plus Inc. to Report Q4, 2023 Results on Feb 27, 2024 5N Plus Inc. announced that they will report Q4, 2023 results After-Market on Feb 27, 2024 Valuation Update With 7 Day Price Move • Feb 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to €2.92, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past year. Recent Insider Transactions • Dec 08
Independent Chairman recently bought €85k worth of stock On the 4th of December, Luc Bertrand bought around 38k shares on-market at roughly €2.24 per share. This transaction amounted to 1.7% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Luc's only on-market trade for the last 12 months. Reported Earnings • Nov 09
Third quarter 2023 earnings released: EPS: US$0.02 (vs US$0.079 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.02 (up from US$0.079 loss in 3Q 2022). Revenue: US$62.9m (down 5.2% from 3Q 2022). Net income: US$1.52m (up US$8.49m from 3Q 2022). Profit margin: 2.4% (up from net loss in 3Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Chemicals industry in Germany. Duyuru • Nov 01
5N Plus Inc. to Report Q3, 2023 Results on Nov 07, 2023 5N Plus Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023 Reported Earnings • Aug 03
Second quarter 2023 earnings released: EPS: US$0.11 (vs US$0.024 loss in 2Q 2022) Second quarter 2023 results: EPS: US$0.11 (up from US$0.024 loss in 2Q 2022). Revenue: US$59.1m (down 18% from 2Q 2022). Net income: US$10.1m (up US$12.3m from 2Q 2022). Profit margin: 17% (up from net loss in 2Q 2022). Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Duyuru • Jul 26
5N Plus Inc. to Report Q2, 2023 Results on Aug 01, 2023 5N Plus Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 01, 2023 Recent Insider Transactions • May 14
Independent Director recently bought €225k worth of stock On the 10th of May, Jean-Marie Bourassa bought around 100k shares on-market at roughly €2.25 per share. This transaction amounted to 6.7% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €798k more in shares than they have sold in the last 12 months. Reported Earnings • May 05
First quarter 2023 earnings released: EPS: US$0.02 (vs US$0.065 loss in 1Q 2022) First quarter 2023 results: EPS: US$0.02 (up from US$0.065 loss in 1Q 2022). Revenue: US$55.3m (down 14% from 1Q 2022). Net income: US$1.45m (up US$7.21m from 1Q 2022). Profit margin: 2.6% (up from net loss in 1Q 2022). Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Recent Insider Transactions • Mar 09
Chief Financial Officer recently sold €316k worth of stock On the 7th of March, Richard Perron sold around 143k shares on-market at roughly €2.22 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months. Reported Earnings • Feb 22
Full year 2022 earnings released: US$0.26 loss per share (vs US$0.038 profit in FY 2021) Full year 2022 results: US$0.26 loss per share (down from US$0.038 profit in FY 2021). Revenue: US$264.2m (up 26% from FY 2021). Net loss: US$23.0m (down US$26.1m from profit in FY 2021). Revenue is forecast to grow 5.7% p.a. on average during the next 2 years, compared to a 1.3% growth forecast for the Chemicals industry in Germany. Duyuru • Feb 15
5N Plus Inc. to Report Q4, 2022 Results on Feb 21, 2023 5N Plus Inc. announced that they will report Q4, 2022 results After-Market on Feb 21, 2023 Recent Insider Transactions • Nov 18
Independent Chairman recently bought €236k worth of stock On the 10th of November, Luc Bertrand bought around 122k shares on-market at roughly €1.93 per share. This transaction amounted to 5.9% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Luc has been a buyer over the last 12 months, purchasing a net total of €569k worth in shares. Reported Earnings • Nov 03
Third quarter 2022 earnings released: US$0.079 loss per share (vs US$0.01 loss in 3Q 2021) Third quarter 2022 results: US$0.079 loss per share (further deteriorated from US$0.01 loss in 3Q 2021). Revenue: US$66.4m (up 31% from 3Q 2021). Net loss: US$6.97m (loss widened US$6.18m from 3Q 2021). Revenue is forecast to grow 11% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Reported Earnings • Aug 03
Second quarter 2022 earnings released: US$0.02 loss per share (vs US$0.027 profit in 2Q 2021) Second quarter 2022 results: US$0.02 loss per share (down from US$0.027 profit in 2Q 2021). Revenue: US$72.4m (up 52% from 2Q 2021). Net loss: US$2.13m (down 199% from profit in 2Q 2021). Over the next year, revenue is forecast to grow 6.1%, compared to a 6.1% growth forecast for the industry in Germany. Recent Insider Transactions • Jun 07
Independent Director recently bought €234k worth of stock On the 30th of May, Jean-Marie Bourassa bought around 197k shares on-market at roughly €1.19 per share. In the last 3 months, there was an even bigger purchase from another insider worth €246k. Insiders have collectively bought €978k more in shares than they have sold in the last 12 months. 
